Kintor Pharmaceutical Ltd (9939) Financial Statements

3 Followers

Kintor Pharmaceutical Ltd Financial Overview

Kintor Pharmaceutical Ltd's market cap is currently HK$1.33B. The company's EPS TTM is HK$-0.44; its P/E ratio is -3.96; Kintor Pharmaceutical Ltd is scheduled to report earnings on March 30, 2026, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Income Statement
Total Revenue	¥ 32.68M	¥ 5.00M	¥ 0.00	¥ 0.00	¥ 34.23M
Gross Profit	¥ 8.04M	¥ -4.73M	¥ -67.63M	¥ -21.38M	¥ 34.23M
Operating Income	¥ -199.78M	¥ -144.57M	¥ -1.06B	¥ -944.53M	¥ -839.60M
EBITDA	¥ -140.66M	¥ -128.37M	¥ -1.06B	¥ -956.45M	¥ -829.09M
Net Income	¥ -200.11M	¥ -155.29M	¥ -1.06B	¥ -954.37M	¥ -842.10M
Balance Sheet
Cash & Short-Term Investments	¥ 34.78M	¥ 147.42M	¥ 455.50M	¥ 875.08M	¥ 1.06B
Total Assets	¥ 340.95M	¥ 515.13M	¥ 869.23M	¥ 2.06B	¥ 2.07B
Total Debt	¥ 86.64M	¥ 133.01M	¥ 253.92M	¥ 286.39M	¥ 159.73M
Net Debt	¥ 51.85M	¥ -14.41M	¥ -191.58M	¥ -578.70M	¥ -770.42M
Total Liabilities	¥ 158.28M	¥ 221.05M	¥ 411.12M	¥ 559.95M	¥ 412.83M
Stockholders' Equity	¥ 182.67M	¥ 294.08M	¥ 458.11M	¥ 1.50B	¥ 1.66B
Cash Flow
Free Cash Flow	¥ -166.07M	¥ -200.76M	¥ -390.30M	¥ -988.73K	¥ -1.13M
Operating Cash Flow	¥ -165.34M	¥ -199.08M	¥ -387.58M	¥ -961.26K	¥ -1.05M
Investing Cash Flow	¥ 14.04M	¥ 20.03M	¥ 3.27M	¥ 67.19K	¥ 92.00K
Financing Cash Flow	¥ 39.23M	¥ -119.67M	¥ -33.46M	¥ 815.75K	¥ 857.42K

Currency in CNY

Kintor Pharmaceutical Ltd Earnings and Revenue History

Income Statement >

Kintor Pharmaceutical Ltd Debt to Assets

Balance Sheet >

Kintor Pharmaceutical Ltd Cash Flow

Cash Flow >

Kintor Pharmaceutical Ltd Forecast EPS vs Actual EPS

Earnings >